Presentation is loading. Please wait.

Presentation is loading. Please wait.

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin.

Similar presentations


Presentation on theme: "Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin."— Presentation transcript:

1 Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin Case Rep Oncol 2016;9:840– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0

2 Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin Case Rep Oncol 2016;9:840– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0

3 Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin Case Rep Oncol 2016;9:840– DOI: / © 2016 The Author(s). Published by S. Karger AG, Basel - CC BY-NC 4.0


Download ppt "Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin."

Similar presentations


Ads by Google